会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • INHIBITION OF FATTY ACID SYNTHESIS BY PARP INHIBITORS AND METHODS OF TREATMENT THEREOF
    • PARP抑制剂抑制脂肪酸的合成及其处理方法
    • WO2008030891A2
    • 2008-03-13
    • PCT/US2007/077662
    • 2007-09-05
    • BIPAR SCIENCES, INC.OSSOVSKAYA, ValeriaSHERMAN, Barry
    • OSSOVSKAYA, ValeriaSHERMAN, Barry
    • A61K31/165A61P3/04A61P9/00
    • A61K31/166A61K31/197A61K31/7012
    • The present invention relates to a method of treating a fatty acid synthesis related disease comprising administering to a patient in need thereof an effective amount of a PARP inhibitor or metabolite thereof to inhibit fatty acid synthesis, wherein the fatty acid synthesis related disease is obesity, diabetes, or cardiovascular disease. The present invention also relates to a method of treating a cancer in a subject comprising: (i) identifying a level of fatty acid in a sample from the subject, and (ii) administering an effective amount of a PARP inhibitor or metabolite thereof to inhibit fatty acid synthesis in the subject, wherein the administration is based on the level of fatty acid, thereby treating the cancer in the subject. The present invention further relates to a method of treating Her-2 related cancers by administering to a patient in need thereof an effective amount of a PARP inhibitor or metabolite thereof to inhibit fatty acid synthesis.
    • 本发明涉及一种治疗脂肪酸合成相关疾病的方法,包括向有需要的患者施用有效量的PARP抑制剂或其代谢物以抑制脂肪酸合成,其中所述脂肪酸合成相关疾病是肥胖症,糖尿病 ,或心血管疾病。 本发明还涉及治疗受试者的癌症的方法,包括:(i)鉴定来自受试者的样品中的脂肪酸水平,和(ii)施用有效量的PARP抑制剂或其代谢物以抑制 受试者中的脂肪酸合成,其中所述给药基于脂肪酸的水平,从而治疗受试者的癌症。 本发明还涉及通过向有需要的患者施用有效量的PARP抑制剂或其代谢物来抑制脂肪酸合成来治疗Her-2相关癌症的方法。
    • 7. 发明申请
    • METHODS OF DIAGNOSING AND TREATING PARP-MEDIATED DISEASES
    • 诊断和治疗PARP介导性疾病的方法
    • WO2009100159A2
    • 2009-08-13
    • PCT/US2009033117
    • 2009-02-04
    • BIPAR SCIENCES INCOSSOVSKAYA VALERIA SSHERMAN BARRY M
    • OSSOVSKAYA VALERIA SSHERMAN BARRY M
    • C12Q1/68A61K48/00C07H21/00C12N15/11
    • C12Q1/6886C12Q2600/106C12Q2600/112C12Q2600/136C12Q2600/158C12Q2600/16G01N2800/52Y02A90/26
    • Disclosed are methods of identifying a disease treatable with modulators of differentially expressed genes in a disease, including at least PARP modulators, by identifying the level of expression of differentially expressed genes, including at least PARP, in a plurality of samples from a population, making a decision regarding identifying the disease treatable by modulators to the differentially expressed genes wherein the decision is made based on the level of expression of the differentially expressed genes. The method can further comprise treating the disease in a subject population with modulators of identified differentially expressed genes. The methods relate to identifying up-regulated expression of identified differentially-expressed genes in a disease and making a decision regarding the treatment of the disease. The level of expression of the differentially expressed genes in a disease can also help in determining the efficacy of the treatment with modulators to the differentially expressed genes.
    • 公开的是通过鉴定来自群体的多个样品中差异表达基因(包括至少PARP)的表达水平,鉴定在疾病中包括至少PARP调节剂的差异表达基因的调节剂可治疗的疾病的方法,使得 关于鉴定通过调节剂可治疗的差异表达基因的决定,其中基于差异表达基因的表达水平进行决定。 该方法还可以包括用鉴别的差异表达基因的调节剂治疗受试群体中的疾病。 该方法涉及鉴定疾病中识别的差异表达基因的上调表达并作出关于疾病治疗的决定。 差异表达基因在疾病中的表达水平也有助于确定用调节剂处理差异表达基因的功效。